Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease.
about
Blood borne transit of CJD from brain to gut at early stages of infectionUltra-sensitive detection of prion protein fibrils by flow cytometry in blood from cattle affected with bovine spongiform encephalopathyRe-assessment of PrP(Sc) distribution in sporadic and variant CJDPrion disease detection, PMCA kinetics, and IgG in urine from sheep naturally/experimentally infected with scrapie and deer with preclinical/clinical chronic wasting disease.First demonstration of transmissible spongiform encephalopathy-associated prion protein (PrPTSE) in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification.Detection of prions in blood.Factor VIII and transmissible spongiform encephalopathy: the case for safety.Haemophilia 2002: emerging risks of treatment.Blood infectivity in transmissible spongiform encephalopathies.Plasminogen-based capture combined with amplification technology for the detection of PrP(TSE) in the pre-clinical phase of infectionFukuoka-1 strain of transmissible spongiform encephalopathy agent infects murine bone marrow-derived cells with features of mesenchymal stem cells.Variant Creutzfeldt-Jakob disease and its transmission by blood.Technical aspects of the development and validation of tests for variant Creutzfeldt-Jakob disease in blood transfusion.Screening assays for transmissible spongiform encephalopathies (TSEs).Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC.Advances in screening test development for transmissible spongiform encephalopathies.Blood infectivity, processing and screening tests in transmissible spongiform encephalopathy.Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob diseasePeripherally administrated prions reach the brain at sub-infectious quantities in experimental hamsters.Proteomic profiling of cerebrospinal fluid in Creutzfeldt-Jakob disease.Role of autophagy in prion protein-induced neurodegenerative diseases.Molecular diagnosis of human prion disease.Detection of infectious prions in urineDetection of PrPsc in blood from sheep infected with the scrapie and bovine spongiform encephalopathy agents.Making blood safer.Test for detection of disease-associated prion aggregate in the blood of infected but asymptomatic animals.Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products?Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases.Effect of protease treatment on plasma infectivity in variant Creutzfeldt-Jakob disease mice.Cellular prion protein is expressed on endothelial cells and is released during apoptosis on membrane microparticles found in human plasma.Comparison of nanofiltration efficacy in reducing infectivity of centrifuged versus ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" albumin solutions.Molecular challenges and viral diseases.Mass spectrometric detection of attomole amounts of the prion protein by nanoLC/MS/MS.A potential blood test for transmissible spongiform encephalopathies by detecting carbohydrate-dependent aggregates of PrPres-like proteins in scrapie-Infected hamster plasma.Monitoring blood transfusion in patients undergoing coronary artery bypass grafting: an audit methodology.Presymptomatic detection of prions in blood.Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.The effects of leukodepletion on the generation and removal of microvesicles and prion protein in blood components.
P2860
Q24795025-BCEF8BEF-B6EB-44D9-AF45-111840F75D46Q24816040-26D35448-5C15-4CC2-BBD6-4ABF3C24EEA9Q28534501-958B17DF-36CD-486B-B4A2-BEBEE176D04FQ34196340-16776F2F-40E7-47E6-B667-4256EE53A6FAQ34355775-A5E3879C-E91D-4DE0-A894-A5710374ACE5Q34446509-C8EE879A-8724-48B0-9A36-8F2132918761Q34600710-841CA732-BEDA-4D37-8DF9-EE2208BD73AEQ34636927-CC2738AB-7D3C-4079-904E-781D08A88A14Q34685468-75B77000-4C5F-4A7A-98D1-BE4A1CF85158Q34874108-5EF90035-2791-4803-8CAC-DE689A32A7EDQ35038696-B2772A6E-7F6C-4AF7-961C-BBADD886A4E2Q35181622-F0DA0B29-B66E-433E-B610-7665371195DFQ35743772-4F954AB7-0D90-4B8C-A435-A7714E53EBF0Q35812894-B49FA25E-B240-4369-8A44-CC4900183E3CQ35865508-61EE91F6-5639-40DA-B818-B987B4A71067Q35964749-78BE6F91-2DA9-48C8-97E7-8C19162B1616Q36230687-8A02714B-8889-41B4-90D8-083749113649Q37449009-13F1D293-559B-4631-B4EB-BF050B1AC8E0Q37693704-4B2DB2C7-071C-49A3-81EA-EE159B0A9CE3Q37818319-D1ACC0E9-EEB0-4C1C-B8B8-A8FC372525F7Q38086413-A489F2CA-668C-450E-88C2-48F95A7B91E2Q38088738-A3C94F06-0770-48B2-9101-044446A4DDF5Q41371006-5620F7B1-3E0E-4025-8E79-0FD5A71F8F7FQ41869692-DC94F995-2752-4B6C-AB29-6537ED3D78F7Q42779279-66EAA5ED-BB86-41AA-A5F6-110A92D813F1Q42956854-E26FC7EA-4A71-42AB-9DF4-4DC56E9FF2D2Q43036585-9E25E960-97B0-464A-A0C7-A989D27E5CBFQ43864071-F24537FF-6B4C-4C14-9AFA-C599736B7463Q43933151-ED82A3BF-AC52-43A3-8D76-3E0976B24C8AQ43964856-548C4C8F-56F9-43F5-9F4C-A0C25B4C1822Q44582815-CC633F92-F34F-4860-AB4F-08B53D0DFC09Q45872085-3BAF3D28-D06C-4B9B-BC4E-E78EAD36D3FCQ46729499-FE18E27C-DE0C-46A1-9829-864D19015291Q46840412-7A24347B-E28B-4D17-9774-BE3BD72BA1E1Q47682203-99808FBC-FA03-413C-889E-D9A16491E390Q48477099-9BC577DC-307C-4055-8DB3-5F7A84FA27A2Q48595468-3A41F076-5939-4CC6-B2D7-EA0A61124520Q50740089-80F525ED-AFAC-4963-83AA-A9D4F1605E9D
P2860
Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Blood infectivity and the pros ...... in Creutzfeldt-Jakob disease.
@ast
Blood infectivity and the pros ...... in Creutzfeldt-Jakob disease.
@en
Blood infectivity and the pros ...... in Creutzfeldt-Jakob disease.
@nl
type
label
Blood infectivity and the pros ...... in Creutzfeldt-Jakob disease.
@ast
Blood infectivity and the pros ...... in Creutzfeldt-Jakob disease.
@en
Blood infectivity and the pros ...... in Creutzfeldt-Jakob disease.
@nl
prefLabel
Blood infectivity and the pros ...... in Creutzfeldt-Jakob disease.
@ast
Blood infectivity and the pros ...... in Creutzfeldt-Jakob disease.
@en
Blood infectivity and the pros ...... in Creutzfeldt-Jakob disease.
@nl
P2093
P356
P1476
Blood infectivity and the pros ...... in Creutzfeldt-Jakob disease.
@en
P2093
Cervenáková L
Diringer H
P356
10.1067/MLC.2001.111951
P577
2001-01-01T00:00:00Z